Skip to main content

Advertisement

Log in

Inducible nitric oxide synthase haplotype associated with migraine and aura

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Migraine is a complex neurological disorder with a clear neurogenic inflammatory component apparently including enhanced nitric oxide (NO) formation. Excessive NO amounts possibly contributing to migraine are derived from increased expression and activity of inducible NO synthase (iNOS). We tested the hypothesis that two functional, clinically relevant iNOS genetic polymorphisms (C−1026A—rs2779249 and G2087A—rs2297518) are associated with migraine with or without aura. We studied 142 healthy women without migraine (control group) and 200 women with migraine divided into two groups: 148 with migraine without aura (MWA) and 52 with aura (MA). Genotypes were determined by real-time polymerase chain reaction using the Taqman® allele discrimination assays. The PHASE 2.1 software was used to estimate the haplotypes. The A allele for the G2087A polymorphism was more commonly found in the MA group than in the MWA group (28 vs. 18%; P < 0.05). No other significant differences in the alleles or genotypes distributions were found (P > 0.05). The haplotype combining both A alleles for the two polymorphisms was more commonly found in the MA group than in the control group or in the MWA group (19 vs. 10 or 8%; P = 0.0245 or 0.0027, respectively). Our findings indicate that the G2087A and the C−1026A polymorphism in the iNOS gene affect the susceptibility to migraine with aura when their effects are combined within haplotypes, whereas the G2087A affects the susceptibility to aura in migraine patients. These finding may have therapeutic implications when examining the effects of selective iNOS inhibitors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Jensen R, Stovner LJ (2008) Epidemiology and comorbidity of headache. Lancet Neurol 7(4):354–361

    Article  PubMed  Google Scholar 

  2. Pietrobon D, Striessnig J (2003) Neurobiology of migraine. Nat Rev Neurosci 4(5):386–398

    Article  PubMed  CAS  Google Scholar 

  3. Bigal ME, Kurth T, Santanello N, Buse D, Golden W, Robbins M, Lipton RB (2010) Migraine and cardiovascular disease: a population-based study. Neurology 74(8):628–635

    Article  PubMed  CAS  Google Scholar 

  4. Dalkara T, Nozari A, Moskowitz MA (2010) Migraine aura pathophysiology: the role of blood vessels and microembolisation. Lancet Neurol 9(3):309–317

    Article  PubMed  CAS  Google Scholar 

  5. Kurth T, Schurks M, Logroscino G, Buring JE (2009) Migraine frequency and risk of cardiovascular disease in women. Neurology 73(8):581–588

    Article  PubMed  Google Scholar 

  6. Goncalves FM, Martins-Oliveira A, Speciali JG, Izidoro-Toledo TC, Luizon MR, Dach F, Tanus-Santos JE (2010) Vascular endothelial growth factor genetic polymorphisms and haplotypes in women with migraine. DNA Cell Biol 29(7):357–362

    Article  PubMed  CAS  Google Scholar 

  7. Martins-Oliveira A, Speciali JG, Dach F, Marcaccini AM, Goncalves FM, Gerlach RF, Tanus-Santos JE (2009) Different circulating metalloproteinases profiles in women with migraine with and without aura. Clin Chim Acta 408(1–2):60–64

    Article  PubMed  CAS  Google Scholar 

  8. Goncalves FM, Martins-Oliveira A, Speciali JG, Luizon MR, Izidoro-Toledo TC, Silva PS, Dach F, Tanus-Santos JE (2011) Endothelial nitric oxide synthase haplotypes associated with aura in patients with migraine. DNA Cell Biol 30(6):363–369

    Article  PubMed  CAS  Google Scholar 

  9. Stam AH, van den Maagdenberg AM, Haan J, Terwindt GM, Ferrari MD (2008) Genetics of migraine: an update with special attention to genetic comorbidity. Curr Opin Neurol 21(3):288–293

    Article  PubMed  Google Scholar 

  10. Goadsby PJ, Lipton RB, Ferrari MD (2002) Migraine–current understanding and treatment. N Engl J Med 346(4):257–270

    Article  PubMed  CAS  Google Scholar 

  11. Olesen J (2008) The role of nitric oxide (NO) in migraine, tension-type headache and cluster headache. Pharmacol Ther 120(2):157–171

    Article  PubMed  CAS  Google Scholar 

  12. Olesen J (2010) Nitric oxide-related drug targets in headache. Neurotherapeutics 7(2):183–190

    Article  PubMed  CAS  Google Scholar 

  13. Sarchielli P, Floridi A, Mancini ML, Rossi C, Coppola F, Baldi A, Pini LA, Calabresi P (2006) NF-kappaB activity and iNOS expression in monocytes from internal jugular blood of migraine without aura patients during attacks. Cephalalgia 26(9):1071–1079

    Article  PubMed  CAS  Google Scholar 

  14. Moncada S, Higgs A (1993) The l-arginine–nitric oxide pathway. N Engl J Med 329(27):2002–2012

    Article  PubMed  CAS  Google Scholar 

  15. Lea RA, Curtain RP, Shepherd AG, Brimage PJ, Griffiths LR (2001) No evidence for involvement of the human inducible nitric oxide synthase (iNOS) gene in susceptibility to typical migraine. Am J Med Genet 105(1):110–113

    Article  PubMed  CAS  Google Scholar 

  16. Jia S, Ni J, Chen S, Jiang Y, Dong W, Gao Y (2011) Association of the pentanucleotide repeat polymorphism in NOS2 promoter region with susceptibility to migraine in a Chinese population. DNA Cell Biol 30(2):117–122

    Article  PubMed  CAS  Google Scholar 

  17. Amaral LM, Palei AC, Sandrim VC, Luizon MR, Cavalli RC, Duarte G, Tanus-Santos JE (2011) Maternal iNOS genetic polymorphisms and hypertensive disorders of pregnancy. J Hum Hypertens. doi:10.1038/jhh.2011.65

  18. Li W, Liu H, Fu L, Li D, Zhao Y (2010) Identification of Yin Yang 1-interacting partners at −1026C/A in the human iNOS promoter. Arch Biochem Biophys 498(2):119–126

    Article  PubMed  CAS  Google Scholar 

  19. Fu L, Zhao Y, Lu J, Shi J, Li C, Liu H, Li Y (2009) Functional single nucleotide polymorphism-1026C/A of inducible nitric oxide synthase gene with increased YY1-binding affinity is associated with hypertension in a Chinese Han population. J Hypertens 27(5):991–1000

    Article  PubMed  CAS  Google Scholar 

  20. Wang SS, Davis S, Cerhan JR, Hartge P, Severson RK, Cozen W, Lan Q, Welch R, Chanock SJ, Rothman N (2006) Polymorphisms in oxidative stress genes and risk for non-Hodgkin lymphoma. Carcinogenesis 27(9):1828–1834

    Article  PubMed  CAS  Google Scholar 

  21. Lee KM, Kang D, Park SK, Berndt SI, Reding D, Chatterjee N, Chanock S, Huang WY, Hayes RB (2009) Nitric oxide synthase gene polymorphisms and prostate cancer risk. Carcinogenesis 30(4):621–625

    Article  PubMed  CAS  Google Scholar 

  22. Sandrim VC, Palei AC, Cavalli RC, Araujo FM, Ramos ES, Duarte G, Tanus-Santos JE (2008) eNOS haplotypes associated with gestational hypertension or preeclampsia. Pharmacogenomics 9(10):1467–1473

    Article  PubMed  CAS  Google Scholar 

  23. Sandrim VC, Palei AC, Luizon MR, Izidoro-Toledo TC, Cavalli RC, Tanus-Santos JE (2010) eNOS haplotypes affect the responsiveness to antihypertensive therapy in preeclampsia but not in gestational hypertension. Pharmacogenomics J 10(1):40–45

    Article  PubMed  CAS  Google Scholar 

  24. Sandrim VC, Palei AC, Sertorio JT, Cavalli RC, Duarte G, Tanus-Santos JE (2010) Effects of eNOS polymorphisms on nitric oxide formation in healthy pregnancy and in pre-eclampsia. Mol Hum Reprod 16(7):506–510

    Article  PubMed  CAS  Google Scholar 

  25. HCSotIH Society (2004) The International Classification of Headache Disorders: 2nd edition. Cephalalgia 24(Suppl 1):9–160

    Google Scholar 

  26. Lacchini R, Metzger IF, Luizon M, Ishizawa M, Tanus-Santos JE (2010) Interethnic differences in the distribution of matrix metalloproteinases genetic polymorphisms are consistent with interethnic differences in disease prevalence. DNA Cell Biol 29(11):649–655

    Article  PubMed  CAS  Google Scholar 

  27. Metzger IF, Sandrim VC, Tanus-Santos JE (2012) Endogenous nitric oxide formation correlates negatively with circulating matrix metalloproteinase (MMP)-2 and MMP-9 levels in black subjects. Mol Cell Biochem 360(1–2):393–399

    Article  PubMed  CAS  Google Scholar 

  28. Stephens M, Smith NJ, Donnelly P (2001) A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68(4):978–989

    Article  PubMed  CAS  Google Scholar 

  29. Johannesen J, Pie A, Pociot F, Kristiansen OP, Karlsen AE, Nerup J (2001) Linkage of the human inducible nitric oxide synthase gene to type 1 diabetes. J Clin Endocrinol Metab 86(6):2792–2796

    Article  PubMed  CAS  Google Scholar 

  30. Lassen LH, Ashina M, Christiansen I, Ulrich V, Grover R, Donaldson J, Olesen J (1998) Nitric oxide synthase inhibition: a new principle in the treatment of migraine attacks. Cephalalgia 18(1):27–32

    Article  PubMed  CAS  Google Scholar 

  31. Hoivik HO, Laurijssens BE, Harnisch LO, Twomey CK, Dixon RM, Kirkham AJ, Williams PM, Wentz AL, Lunnon MW (2010) Lack of efficacy of the selective iNOS inhibitor GW274150 in prophylaxis of migraine headache. Cephalalgia 30(12):1458–1467

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by Fundação de Amparo à Pesquisa do Estado de São Paulo, Conselho Nacional de Desenvolvimento Científico e Tecnológico and Coordenadoria de Aperfeiçoamento de Pessoal de Nível Superior.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jose E. Tanus-Santos.

Rights and permissions

Reprints and permissions

About this article

Cite this article

de O. S. Mansur, T., Gonçalves, F.M., Martins-Oliveira, A. et al. Inducible nitric oxide synthase haplotype associated with migraine and aura. Mol Cell Biochem 364, 303–308 (2012). https://doi.org/10.1007/s11010-012-1231-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11010-012-1231-0

Keywords

Navigation